9BL-39247-55682
4 vaccinations
5 coded responses
35 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 148 / NY
- Registered
- 2021-02-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Moderna
-
2021-02-12
Dose 2 — Moderna
-
2021-02-13
Registered in v-safe
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fever · Chills, DiarrheaFree text: SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
-
2021-08-13
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pregnancy and it's corresponding first trimester symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-05
Dose 3 — Moderna
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2022-02-04
-
2022-05-06
Survey response — 6 months, dose 3MedDRA: Foetal growth abnormality, Gestational diabetes, Hospitalisation, Hyperemesis gravidarum, Office visit, Polyhydramnios, Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy-related: hyperemesis gravidarum, diet-controlled gestational diabetes, mild polyhydramnios. Infant diagnosed with bilateral renal pelviectasis and tested coombs positive d/t ABO incompatibility. · Healthcare visit (other): Normal ob appointments/birth-related hospitalization: did get non stress test and biophysical profile toward end of pregnancy d/t mild Polyhydramnios and large estimated fetal size.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-05-09
-
2022-09-17
Dose 4 — ModernaCo-administered: Flu
- 2022-09-29
- 2022-10-01
-
2022-10-08
Survey response — day 21, dose 4MedDRA: Nasopharyngitis, Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Cold sx: congestion, fever, runny nose. Tested negative twice.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-17
- 2022-10-22
- 2022-10-29
- 2022-12-17
-
2023-03-18
Survey response — 6 months, dose 4MedDRA: Influenza, Respiratory syncytial virus infection, Respiratory tract infection, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-18
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-20
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-09-17 | Moderna | Flu |
Call center
2 call center cases
2 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Sweating
Release 9 — 6 months, dose 2
Symptoms: Pregnancy and it's corresponding first trimester symptoms
Release 11 — 6 months, dose 3
Symptoms: Pregnancy-related: hyperemesis gravidarum, diet-controlled gestational diabetes, mild polyhydramnios. Infant diagnosed with bilateral renal pelviectasis and tested coombs positive d/t ABO incompatibility.
Healthcare visit (other): Normal ob appointments/birth-related hospitalization: did get non stress test and biophysical profile toward end of pregnancy d/t mild Polyhydramnios and large estimated fetal size.
Release 12 — day 21, dose 4
Symptoms: Cold sx: congestion, fever, runny nose. Tested negative twice.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Foetal growth abnormality | · | · | ✓ |
| HCVO | Hospitalisation | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Polyhydramnios | · | · | ✓ |
| HCVO | Pregnancy | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
| SD | Hyperemesis gravidarum | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Polyhydramnios | · | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release